Session 2: mRNA LNP scale up for GMP Vaccine Production - Dr. Jason Coleman

Scale-up and Manufacturing of Self-amplifying RNA-LNPs for a COVID-19 VaccineПодробнее

Session 2: Development of an RNA LNP Covid 19 Vaccine - Dr. Jagbir SinghПодробнее

Scale Up and Manufacturing of RNA-LNPs for a COVID-19 VaccineПодробнее

Accelerating Development of saRNA-Lipid Nanoparticle VaccinesПодробнее

Developing Scalable RNA-LNP Drug Products for Clinical ReadinessПодробнее

GMP Manufacturing of Messenger RNA Therapeutics and Vaccines: Case Study of a SA SARS CoV-2 VaccineПодробнее

West Webinar - Scale Up: Bringing Nanomedicine from the Lab to the ClinicПодробнее

Process & Analytical Insights for GMP Manufacturing of mRNA-Lipid NanoparticlesПодробнее

Translating mRNA-Based Medicines from Concept to ClinicПодробнее

Lipid nanoparticle (LNP) production for mRNA-based vaccinesПодробнее

Is RNA Medicine the Next Paradigm Shift? Precision NanoSystems and the CRS BNLF Local ChapterПодробнее

Session 3: Addressing vaccine demand with rapid deployment of mRNA manufacturing - Joe MakowieckiПодробнее

Using nanopore sequencing to understand the manufacture, delivery, and action of mRNA vaccinesПодробнее

NanoAssemblr™ GMP Scale-Up System | Ray Lockard, Precision NanoSystemsПодробнее

LNP delivery system for a COVID 19 self amplifying mRNA vaccineПодробнее

Overcoming Key Challenges in Vaccine DevelopmentПодробнее

Session 1: Translation of RNA Nanomedicines from Design to Clinical - Dr. Heinrich HaasПодробнее

Standardizing Scale-up: Insights into Producing Clinical and Commercial RNA-LNP Drug ProductsПодробнее

TMS 9/12/21 ''Manufacturing of nucleic acid lipid nanoparticles for vaccine development''Подробнее